SEC Comment Letter for Jaguar Health, Inc. (JAGX) (CIK 0001585608) (JAGX) — Apr 30, 2019

Jaguar Health, Inc. (JAGX) (CIK 0001585608)
Date: April 30, 2019 · CIK: 0001585608 · Accession: 0000000000-19-007797

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-36714

Date

April 30, 2019

Author

Lisa Conte

Form

UPLOAD

Company

Jaguar Health, Inc. (JAGX) (CIK 0001585608)

Letter

April 30, 2019 Lisa Conte Chief Executive Officer & President Jaguar Health, Inc. 201 Mission Street, Suite 2375 San Francisco, CA 94105 Re:Jaguar Health, Inc. Preliminary Proxy Statement on Schedule 14A Filed March 22, 2019 File No. 001-36714 Dear Ms. Conte: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: Michael Lee - Reed Smith LLP

Show Raw Text

April 30, 2019
Lisa Conte
Chief Executive Officer & President
Jaguar Health, Inc.
201 Mission Street, Suite 2375
San Francisco, CA 94105
Re:Jaguar Health, Inc.
Preliminary Proxy Statement on Schedule 14A
Filed March 22, 2019
File No. 001-36714
Dear Ms. Conte:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc:       Michael Lee - Reed Smith LLP

SecProbe.io